EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Synergic cancer chemo-immunotherapy comprising combined doxorubicin and siRNA targeting CD47 co-delivered by a bola-amphiphilic dendrimer

Baoping Lian, Dandan Zhu, Peng Chen, Zhihui Wang, Fanzhen Meng, Ran Yan, Nikolay A Pyataev, Xiaoxuan Liu

Biomaterials Science · 2026

DOI: 10.1039/d6bm00031b ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Baoping Lian und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Joint International Research Laboratory of Target Discovery and New Drug Innovation (Ministry of Education…. Hauptthemen laut MEDLINE: Doxorubicin, CD47 Antigen, RNA, Small Interfering, Dendrimers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, National Basic Research Program of China, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Restoring antitumor immunity while enhancing the chemotherapy efficacy represents an optimistic strategy for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCD47 AntigenRNA, Small InterferingDendrimersImmunotherapyAnimalsHumansMiceCell Line, TumorPhagocytosisMacrophages

Substanzen

DoxorubicinCD47 AntigenRNA, Small InterferingDendrimersCD47 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Joint International Research Laboratory of Target Discovery and New Drug Innovation (Ministry of Education), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Ce…
  • Aix-Marseille Université, 163 avenue de Luminy, 13288 Marseille, France.
  • Key Laboratory of Biomedical Functional Materials, China Pharmaceutical University, Nanjing 211198, P. R. China.
  • National Research Ogarev Mordovia State University, Bolshevistskaya Str. 68, 430005 Saransk, Russia.

Förderung

  • National Natural Science Foundation of China
  • National Basic Research Program of China
  • China Scholarship Council

Zitieren

APA

Lian, B., Zhu, D., Chen, P., Wang, Z., Meng, F., Yan, R., Pyataev, N. A., & Liu, X. (2026). Synergic cancer chemo-immunotherapy comprising combined doxorubicin and siRNA targeting CD47 co-delivered by a bola-amphiphilic dendrimer. Biomaterials Science. https://doi.org/10.1039/d6bm00031b

Vancouver

Lian B, Zhu D, Chen P, Wang Z, Meng F, Yan R, et al. Synergic cancer chemo-immunotherapy comprising combined doxorubicin and siRNA targeting CD47 co-delivered by a bola-amphiphilic dendrimer. Biomaterials Science. 2026. doi:10.1039/d6bm00031b

BibTeX
@article{Lian2026,
  author = {Lian, Baoping and Zhu, Dandan and Chen, Peng and Wang, Zhihui and Meng, Fanzhen and Yan, Ran and Pyataev, Nikolay A and Liu, Xiaoxuan},
  title = {Synergic cancer chemo-immunotherapy comprising combined doxorubicin and siRNA targeting CD47 co-delivered by a bola-amphiphilic dendrimer},
  journal = {Biomaterials Science},
  year = {2026},
  doi = {10.1039/d6bm00031b}
}
Kostenlos starten →